期刊文献+

N-乙酰半胱氨酸对造影剂肾病预防效果的系统评价 被引量:5

A Meta Analysis of the Prevention of Contrast-induced Nephropathy Using N-acetylcysteine
下载PDF
导出
摘要 目的系统评价N-乙酰半胱氨酸(NAC)对造影剂肾病(contrast induced nephropathy,CIN)的预防效果。方法检索1994~2011年PuMed数据库、万方数据库及中国知网,按Cochrane Handbook for Systematic Reviews ofIntervention质量评价标准,用Review Manager 5.1软件对符合质量标准的随机对照试验(RCT)文献进行Meta分析。结果本研究初步检索出168篇相关文献,有13篇RCT文献入选,共纳入患者1533例,单纯水化组770例,水化+NAC组763例。结果显示在水化治疗的基础上应用NAC,与单纯水化比较差异有统计学意义[OR=0.46,95%CI(0.34,0.62)]。结论在水化基础上应用NAC预防CIN效果显著。 Objective The objective of this study was to assess the effectiveness of N-acetylcysteine for prevention of contrast induced nephropathy.Methods We searched Pubmed,Wanfang and CNKI databases for trials using N-acetylcysteine to prevent contrast-induced nephropathy during 1994 and 2011.Meta-analysis was conducted for the eligible RCT.Results A total of 13 trials and 1533 subjects were pooled.This updated meta-analysis found N-acetylcysteine to be useful for the prevention of contrast-induced nephropathy.And further analysis showed that N-acetylcysteine with hydration group(n=763) was more useful than only hydration group(n=770) with significant difference.Conclusion N-acetylcysteine has been found to be useful in the prevention of contrast-induced nephropathy.And N-acetylcysteine with hydration is more effective than placebo with hydration.
出处 《临床误诊误治》 2012年第4期45-48,共4页 Clinical Misdiagnosis & Mistherapy
基金 湖北省自然科学基金重点项目(2008ADA054) 中央高校基本科研业务费专项资金(20103020201000196)
关键词 乙酰半胱氨酸 造影剂肾病 META分析 评价研究 Acetylcysteine Contrast induced nephropathy Meta analysis Evaluation study
  • 相关文献

参考文献25

  • 1Mc Cullough P A,Wolyn R,Rocher L L,et al.Acuterenal fallure after coronary Interventlon:lncidence,riskfactors,and relationship to mortality[J].Am J Med,1997,103(5):368-375.
  • 2Liistro F,Falsinl G,Bologneae L,et al.The Clinicalburden of contrast-media-induced nephropathy[J].HalHeart J,2003,4(10):668.
  • 3Higgins J P,Green S.Cochrane Handbook for SystematicReviews of Interventions version 5.0.2[M].The Co-chrane Collaboration,2009:201-203.
  • 4Amini M,Salarifar M,Amirbaigloo A,et al.N-acetyl-cysteine does not prevent contrast-induced nephropathyafter cardiac catheterization in patients with diabetes mel-litus and chronic kidney disease:a randomized clinicaltrial[J].Trials,2009,10:45.
  • 5Carbonell N,Sanjuan R,Blasco M,et al.N-acetylcys-teine:short-term clinical benefits after coronary angiogra-phy in high-risk renal patients[J].Rev Esp Cardiol,2010,63(1):12-19.
  • 6崔荣,王丹.应用N-乙酰半胱氨酸对冠心病合并糖尿病的患者发生造影剂肾病的预防作用[J].黑龙江医学,2010,34(8):573-575. 被引量:2
  • 7丁晓隽,李慧华.急性冠状动脉综合征患者介入治疗中N-乙酰半胱氨酸对造影剂相关性肾病保护作用的临床研究[J].中华临床医师杂志(电子版),2011,5(15):4499-4501. 被引量:3
  • 8Durham J D,Caputo C,Dokko J,et al.A randomizedcontrolled trial of N-acetylcysteine to prevent contrast ne-phropathy in cardiac angiography[J].Kidney Int,2002,62(6):2202-2207.
  • 9Ferrario F,Barone M T,Landoni G,et al.Acetylcys-teine and non-ionic isosmolar contrast-induced nephropa-thy-a randomized controlled study[J].Nephrol DialTransplant,2009,24(10):3103-3107.
  • 10惠海鹏,朱平,李开亮,张帏,刘志英,刘玉春.N-乙酰半胱氨酸对老年冠心病患者造影剂肾病的保护作用[J].临床误诊误治,2009,22(3):14-16. 被引量:14

二级参考文献70

  • 1吉俊,丁小强,许迅辉,邹建洲,何建强,林贻梅,柏瑾,钱菊英.低渗非离子造影剂对冠状动脉介入诊疗术患者肾功能影响的前瞻性研究[J].中华肾脏病杂志,2006,22(7):388-392. 被引量:46
  • 2王沆,郭平凡.造影剂肾病[J].医学综述,2007,13(8):594-596. 被引量:18
  • 3Berg KJ. Nephrotoxicity related to contrast media. SCINd J Urol Nephrol, 2000,34 : 317-322.
  • 4Zagler A, Azadpour M. N-Acetylcysteine and contrast-induced nephropathy: a meta - analysis of 13 randomized trials. Am Heart J,2006, 151 : 140-145.
  • 5Aspelin P. Nephrotoxicity and the role of contrast media. Radiat Med,2004 ,22:377-378.
  • 6Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol, 2008 , 15:812-819.
  • 7Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast neplaropathy: meta-analysis. Lancet, 2003, 23: 598- 603.
  • 8Zafarullah M,Li WQ, Sylvester J, et al. Molecular mechanisms of N-acetyleysteine actions. Cell Mol Life Sci, 2003,60 : 6-20.
  • 9Chen N, Aleksa K, Woodland C, et al. N-Aeetyleysteine prevents ifosfamide-induced nephrotoxicity in rats. Br J Pharmacol, 2008, 153: 1364-1372.
  • 10Luo J,Tsuji T, Yasuda H, et al. The molecular mechanisms of the attenuation of cisplatininduced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant, 2008,23 : 2198-2205.

共引文献68

同被引文献67

  • 1邹古明,颜红兵.造影剂肾病的诊断与治疗现状[J].中国介入心脏病学杂志,2005,13(3):194-196. 被引量:78
  • 2段绍斌,周晓蓉,彭佑铭,刘伏友,李伟芳,唐珂,刘瑞洪,李桂源.高渗和低渗造影剂对人肾小管上皮细胞的毒性作用[J].中华肾脏病杂志,2006,22(2):88-93. 被引量:17
  • 3张庆娟(综述),刘殿阁(审校).造影剂肾病的防治进展[J].国际泌尿系统杂志,2007,27(1):117-120. 被引量:15
  • 4侯晓平,缪京莉,伦立德,郑晓勇,张婧.血液透析预防和救治老年造影剂相关肾病[J].中华老年多器官疾病杂志,2006,5(4):300-301. 被引量:3
  • 5Seeliger E,Sendeski M,Rihal CS,et al.Contrast-induced kidney injury: mechanisms,risk factors,and prevention[J].Eur Heart J,2012,33 (16):2007-2015.
  • 6Wong PCY,Li ZC,Guo J,et al.Pathophysiology of contrast-induced nephropathy [J].Int J Cardiol,2012,158(2):186-192.
  • 7Solomon RJ,Mehran R,Natarajan MK,et al.Contrast-induced nephropathy and long-term adverse events:cause and effect[J].Clin J Am Soc Nephrol,2009,4(7):1162-1169.
  • 8Shemirani H,Pourrmoghaddas M.A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention[J]. Saudi J Kidney Dis Transpl,2012,23(2):280-285.
  • 9Vercellino M,Bezante GP,Balbi M.Contrast medium induced nephropathy: new insights into prevention and risk management[J],Cardiovasc Hematol Agents Med Chem,2009,7(2):166-80.
  • 10Thomsen HS.European Society of Urogenital Radiology guidelines on contrast media application[J].Curr Opin Urol,2007,17(1):70-76.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部